FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

The Evidence-Based Drug Policy Act of 2025 seeks to remove federal barriers to researching Schedule I substances like ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

As of March 31, 2025, Tonix had $131.7 million of cash and cash equivalents, compared to $98.8 million as of December 31, 2024. Net cash used in operations was approximately $16.6 million for first ...

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...

Trump's executive order sets a deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits ...

The Food and Drug Administration (FDA) recently announced that it had identified “significant data integrity and study conduct concerns” ...

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...